DIESSE is an Italian company with an integrated and entirely inhouse production of in vitro diagnostic systems. Its headquarters are in Siena.
Since its foundation in 1980, the company has developed, produced and marketed innovative diagnostic systems mainly in the area of immunochemistry and automatic measurement of ESR. The company features a worldwide presence in over 100 countries. In its headquarters, including research center and manufacturing plant, the design and implementation of tests and new diagnostic instruments meets Italian design and cutting-edge technology, identifying DIESSE as the “Diagnostics for the Immune System.”
We use our history and our skills in everyday work, integrating advanced research, Made in Italy production and global marketing, for the evolution of our diagnostics systems towards the medicine of future in a sustainable, ethical and transparent way.
- Ethics & sustainability
- Transparency
- Sense of belonging
- Research & innovation
- Sharing
- Expertise
- Tenacity
- People center
DIESSE has been part of the portfolio of companies managed by ArchiMed, Europe’s first independent private equity fund specialised in healthcare, since 2019. In compliance with the provisions contained in the Legislative Decree 8/06/2001, n231, DIESSE prepared the Organisation, Management and Control Model pursuant to Legislative Decree.
DIESSE has been operating for many years in accordance with leading standards for quality management systems, ensuring traceability, transparency, highest quality of its processes, products and services and working on continuous improvement.
DIESSE is committed to conducting, executing, and monitoring its activities in an ethical, socially responsible and transparent way to safeguard the respect and preservation of the environment, as well as cultural and social heritage, in order to protect this generation and those to come.
DIESSE guarantees the "right to know" of its own relationships of economic importance with professionals in the health sector and health organizations, also in compliance with the principles and behaviors of its own Code of Ethics.
DIESSE ha effettuato l’adeguamento al Decreto Legislativo 10 marzo 2023, n. 24 sulla gestione delle segnalazioni degli illeciti.
